Publications by authors named "Thomas van Es"

Claim this Profile
C
Co-constructing Markov blankets: Tricky solutions: Comment on "The Markov blanket trick: On the scope of the free energy principle and active inference" by Vicente Raja et al.
Thomas van Es, Inês Hipólito

Phys Life Rev· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Free-energy pragmatics: Markov blankets don't prescribe objective ontology, and that's okay.
Inês Hipólito, Thomas van Es

Behav Brain Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enactive-Dynamic Social Cognition and Active Inference.
Inês Hipólito, Thomas van Es

Front Psychol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intradermal delivery of TLR agonists in a human explant skin model: preferential activation of migratory dendritic cells by polyribosinic-polyribocytidylic acid and peptidoglycans.
Dinja Oosterhoff, Moniek Heusinkveld, Sinéad M Lougheed, Ilona Kosten, Malin Lindstedt, Thomas van Es

J Immunol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular players in lung fibrosis.
Annemarie N Lekkerkerker, Jamil Aarbiou, Thomas van Es, Richard A J Janssen

Curr Pharm Des· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine.
Rolf J Verheul, Niels Hagenaars, Thomas van Es, Ethlinn V B van Gaal, Pascal H J L F de Jong

Eur J Pharm Sci· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient mice.
Thomas van Es, Gijs H M van Puijvelde, Ingrid N Michon, Eva J A van Wanrooij, Paula de Vos

Vaccine· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A vaccine against atherosclerosis: myth or reality?
Gijs Hm van Puijvelde, Thomas van Es, Kim Ll Habets, Arnaud D Hauer, Theo Jc van Berkel

Future Cardiol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice.
Eva J A van Wanrooij, Saskia C A de Jager, Thomas van Es, Paula de Vos, Helen L Birch, Erik A L Biessen

Arterioscler Thromb Vasc Biol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulation of the inflammatory response in atherosclerosis.
Johan Kuiper, Gijs H M van Puijvelde, Eva J A van Wanrooij, Thomas van Es, Kim Habets

Curr Opin Lipidol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis